Lee Ainslie - Maverick Capital
Holding/activity history for Bristol-Myers Squibb (BMY)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2021 Q2 | 0 | 0 | Sell 100.00% | 0.02 | |
| 2021 Q1 | 40,241 | 0.02 | Add 78.46% | 0.01 | $63.12 |
| 2020 Q4 | 22,549 | 0.02 | Add 214.62% | 0.01 | $62.04 |
| 2020 Q3 | 7,167 | 0.01 | Reduce 89.04% | 0.08 | $60.28 |
| 2020 Q2 | 65,373 | 0.08 | Reduce 5.19% | 0.00 | $58.80 |
| 2020 Q1 | 68,953 | 0.08 | Reduce 40.17% | 0.05 | $55.73 |
| 2019 Q4 | 115,253 | 0.11 | Reduce 7.44% | 0.01 | $64.19 |
| 2019 Q3 | 124,512 | 0.09 | Add 2.90% | 0.00 | $50.71 |
| 2019 Q2 | 121,000 | 0.08 | Reduce 12.36% | 0.01 | $45.35 |
| 2019 Q1 | 138,060 | 0.09 | Buy | 0.09 | $47.71 |
| 2018 Q4 | 0 | 0 | Sell 100.00% | 0.11 | |
| 2018 Q3 | 148,610 | 0.11 | Buy | 0.11 | $62.08 |